Sign in
Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)
Journal article   Peer reviewed

Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)

G Esmat, H ElMakhzangy, S Males, R Gad, C Rekacewicz, S A Ismail, M Abdel-Hamid, M El-Daly, S Pol, A Fontanet, …
Journal of clinical virology, Vol.36, pp.S138-S138
01/01/2006

Metrics

1 Record Views

Details